Intravenous Immunoglobulin Therapy in COVID-19 Disease
High dose IVIG has been an appropriate immunomodulatory treatment option for prophylaxis of severe infections in autoimmune and inflammatory diseases [1]. It is suggested that the plasma levels of pro-inflammatory cytokines are higher in COVID-19 patients with severe clinical course and there is a c...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Sakarya University
2021-06-01
|
| Saila: | Sakarya Tıp Dergisi |
| Gaiak: | |
| Sarrera elektronikoa: | https://dergipark.org.tr/tr/download/article-file/1308957 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|